Sequana Medical NV (Sequana Medical NV) COGS-to-Revenue : 0.23 (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV COGS-to-Revenue?

Sequana Medical NV's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.10 Mil. Its Revenue for the three months ended in Jun. 2023 was $0.42 Mil.

Sequana Medical NV's COGS to Revenue for the three months ended in Jun. 2023 was 0.23.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sequana Medical NV's Gross Margin % for the three months ended in Jun. 2023 was 77.16%.

Sequana Medical NV COGS-to-Revenue Historical Data

The historical data trend for Sequana Medical NV's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV COGS-to-Revenue Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.15

0.20

0.21

0.22

Sequana Medical NV Quarterly Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial									0.21	0.21	0.22	0.22	0.23

Sequana Medical NV COGS-to-Revenue Calculation

Sequana Medical NV's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.217	/	0.978
	=	0.22

Sequana Medical NV's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.095	/	0.416
	=	0.23

Sequana Medical NV (GREY:SQNMF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sequana Medical NV's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.095 / 0.416
	=	77.16 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sequana Medical NV COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (Sequana Medical NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines